-
Cost-Consequence Analysis of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Treatment vs. Large-Volume Paracentesis (LVP) in the Management of Refractory Ascites: Preliminary Results Overview From an Italian Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Importance of Decisional Context in the Health Technology Assessment (HTA) of Advanced Therapy Medicinal Products (ATMPs)
Sep 9, 2025, 16:22 PM -
CDF or CDFoe: How Has the Cancer Drugs Fund Impacted Access to Atezolizumab for Patients With Non-Small Cell Lung Cancer in the Adjuvant Setting?
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis Of Erdosteine for the Prevention of Exacerbations in Patients With COPD in the Czech Republic
Sep 9, 2025, 16:22 PM -
Country-Related Differential Item Functioning in the EQ-5D-5L: Insights From the EuroQol Data Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE)
Sep 9, 2025, 16:22 PM -
Economics of Improved Time in Range in Type 1 Diabetes Management in Italy, Spain, Greece, and Israel
Sep 9, 2025, 16:22 PM -
Occurrence of Exacerbations and Mortality in High-Risk Chronic Obstructive Pulmonary Disease Patients While on Treatment With Dual or Triple Inhaled Therapy: Results From the SIRIUS Observational Study in the US
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Quizartinib for Adult Patients With Newly Diagnosed FLT3-ITD+ Acute Myeloid Leukemia (AML) in Spain
Sep 9, 2025, 16:22 PM -
Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals
Sep 9, 2025, 16:22 PM -
How Societal Is Sweden? A Study of Inclusion of Societal Costs in Swedish Reimbursement Decisions
Sep 9, 2025, 16:22 PM -
Sex Differences in Chronic Hand Eczema (CHE) Triggering Factors: Comorbidities, Lifestyle, and Exposures Findings From a Multinational Study in Six Countries
Sep 9, 2025, 16:22 PM -
Evaluation of the Effectiveness of a Naturalness Probe for Assessing Human- and Nonhuman-Generated COA Translations in Linguistic Validation Cognitive Debriefing Interviews
Sep 9, 2025, 16:22 PM -
First-Trimester Screening for Preterm Pre-Eclampsia in the United Kingdom: A Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Reconsidering Generic Utilities: Implications for Equitable Health Technology Appraisal
Sep 9, 2025, 16:22 PM -
Pain and Fatigue Assessment and Evaluation in Oncology Trials
Sep 9, 2025, 16:22 PM -
Assessing Bias in LLM-Extracted Real-World Data: A Health Equity Analysis of Access to Care and Outcomes in Metastatic Breast Cancer
Sep 9, 2025, 16:22 PM -
Optimization of the EVAR Pathway: An Integrated Organizational Model for Clinical Efficiency and Economic Sustainability
Sep 9, 2025, 16:22 PM -
Can Switching From Intravenous (IV) to Subcutaneous (SC) Formulations Save Time and Resources? A Service Impact Model (SIM)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of CKD Screening: Insights for the 60+ General Population and Those With Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
What Prompt Engineering Missed and How Context Engineering Fixes It
Sep 9, 2025, 16:22 PM
